Myo Zaw
Geriatric Medicine · Stockton, CANPI 1083022925
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,667 of the $3,297 with a category attached, or 80.9%. 25 manufacturers reported payments, led by Medtronic at 26.3% of the total. Reporting peaked in 2020 at $1,869 and has fallen 92.6% since, to $138 in 2023.
Across 150 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$869
- AbbVie$389
- Johnson & Johnson$314
- AstraZeneca$239
- GSK$208
- Amgen$171
- plus $1K from 19 others
What the payments were for
- Travel & lodging$63019%
- Food & beverage$2,66781%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $869 |
| AbbVie(2 entities) | 25 | $389 |
| Johnson & Johnson | 30 | $314 |
| AstraZeneca | 2 | $239 |
| GSK | 11 | $208 |
| Amgen | 7 | $171 |
| Lilly USA, LLC | 10 | $158 |
| Novo Nordisk | 15 | $154 |
| Genentech USA, Inc. | 1 | $135 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Amarin Pharma, Inc. | 5 | $93 |
| Corcept Therapeutics | 3 | $80 |
| Boehringer Ingelheim | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Astellas Pharma US Inc | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Novartis | 2 | $33 |
| Dexcom, Inc. | 2 | $32 |
| Eisai Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Biogen | 1 | $17 |
| Abbott | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Minimed 670G System$688
- TECENTRIQ$135
- TAGRISSO$122
- Enhertu$118
How this compares
$3,297 in reported general payments places this provider in the 85th percentile of 494 geriatric medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 12 | $19,372 |
| JardianceEmpagliflozin | 69 | $18,439 |
| XareltoRivaroxaban | 30 | $9,799 |
| EliquisApixaban | 14 | $5,411 |
| Insulin Glargine-Yfgn | 60 | $3,806 |
| Atorvastatin Calcium | 165 | $3,335 |
| Gabapentin | 105 | $2,569 |
| Memantine Hcl | 52 | $2,495 |
| HumalogInsulin Lispro | 31 | $2,237 |
| Divalproex Sodium | 33 | $1,859 |
| Trazodone Hcl | 53 | $1,762 |
| Humalog Kwikpen U-100Insulin Lispro | 20 | $1,692 |
| Lisinopril | 96 | $1,634 |
| Pantoprazole Sodium | 50 | $1,534 |
| Trospium Chloride | 15 | $1,466 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $34 | $19,37212 claims |
| Boehringer IngelheimJardiance | $63 | $18,43969 claims |
| Johnson & JohnsonXarelto | $314 | $9,79930 claims |
| Lilly USA, LLCHumalog, Humulin N | $158 | $3,29851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 494 geriatric medicine providers in California.
Other geriatric medicine in Stockton
- Robert FeldmanLaguna Hills$1.2M
- Oscar ChienSan Gabriel$208K
- Anders NybergSan Diego$160K
- Paul AisenSan Diego$70K
- Wayne ChenLos Angeles$40K
- Vincent HoLancaster$32K
- Kathryn SewellSan Francisco$26K
- Stephen HenryPasadena$25K
- Chaewon SongGarden Grove$21K
- Douglas ZhangSan Leandro$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.